Although not everything on the Choosing Wisely lists is likely to reduce low-value care, it is a good starting point for a conversation about curtailing low-value interventions.
The Oxford Centre for Evidence-Based Medicine provides a scale for stratifying evidence from strongest to weakest on the basis of susceptibility to bias and the quality of study design.
Comparative effectiveness research (CER) may become an important factor in Medicare coverage decisions, and the new health care law may make it more easily available to the public to help in medical decision making.
Despite exclusion of cost from the definition of comparative effectiveness research from the recent health care reform legislation, it will feed into cost-benefit analyses.
Specific advocate guidelines are needed for the protection of children in state custody who are potential research subjects in trials that would expose them to greater-than-minimal risk but also hold the prospect of direct benefit.
In “Allocating Scare Resources in a Pandemic,” Martin Strosberg calls attention to the need for preparedness planning including methods for rationing vaccines, antiviral medications, and intensive care unit beds and staff.
An examination of the effect that the Mammography Quality Standards Act has had on training and certification of radiologists and mammography technicians.